- Novartis Healthcare Philippines and Asian Hospital and Medical Center have launched a partnership that aims to enhance health literacy and broaden access to innovative medicines for breast cancer and dyslipidemia
Novartis Healthcare Philippines and Asian Hospital and Medical Center (AHMC) have launched a partnership that aims to enhance health literacy and broaden access to innovative medicines for breast cancer and dyslipidemia.
“Novartis is committed to get the right treatment to the right patient, at the right time as quickly as possible. As such, we are pleased to partner with one of the country’s most advanced healthcare institutions, Asian Hospital and Medical Center, in achieving our shared goal of enhancing health literacy and broadening access to life-saving innovative medicines,” said Mr. Joel Chong, Country President, Novartis Healthcare Philippines.
“This partnership complements our ‘Alagang Deserve, Alagang Sulit’ campaign by providing access to affordable specialty medicines that are most appropriate for our patient’s medical condition. This is a critical factor in achieving positive health outcomes and improving overall quality of life.” Dr. Beaver Tamesis, President and Chief Executive Officer, AHMC.
The partnership aims to broaden access to innovative medicines by co-creating healthcare solutions for better patient outcomes. These include promoting patient awareness on breast cancer and dyslipidemia management; enhance healthcare professionals’ knowledge and understanding on breast cancer and atherosclerotic cardiovascular disease (ASCVD) and improve their capacity to manage patients; and enhance patient adherence through value-added services which will help improve patient outcomes.
Novartis and AHMC will collaborate on the #Unblocked campaign, aiming to raise awareness about the importance of managing ASCVD (Atherosclerotic Cardiovascular Disease), LDL-c control, and finding ways to remove barriers to heart health. This partnership will also focus on capacity building initiatives, specifically for pharmacists, medical social workers, and equivalent personnel. The collaboration seeks to improve access to effective treatments and provide comprehensive care for Filipinos facing cardiovascular health challenges.
Photo shows (from left) Ms. Margarita Bondoc, Cardiovascular Therapeutic Head, Novartis Healthcare Philippines; Mr. Joel Chong, Country President, Novartis Healthcare Philippines; Dr. Beaver Tamesis, President and Chief Executive Officer, AHMC; Mr. Sushant Anand, Value & Access Head, Novartis Healthcare Philippines; and Ms. Christina Liza R. Sta. Maria, Pharmacy Services Head, AHMC.
About Asian Hospital and Medical Center
Established on May 11, 2002, AHMC is a member of the Metro Pacific Health, the largest Philippine-based private hospital group managed by the Metro Pacific Investments Corporation (MPIC), the local unit of the First Pacific Group headed by Mr. Manuel V. Pangilinan.
AHMC is a comprehensive healthcare facility spanning 17,250 square meters with 296 beds, designed to provide a safe, comfortable, and hotel-like environment for patients. The hospital employs over 1,000 doctors specializing in Cardiology, Oncology, Neurosciences, Gastroenterology, Orthopedics, and many other fields. Additionally, it staffs more than 400 skilled nurses and approximately 1,000 other staff members, all dedicated to delivering compassionate and integrative healthcare. Driven by values such as fairness, integrity, teamwork, excellence, and respect, AHMC continuously seeks to improve clinical outcomes, patient safety, and disease management. Located for easy access via the Filinvest exit on the Southern Luzon Expressway, AHMC ensures that excellent healthcare is readily accessible from both urban and suburban areas.
About Novartis
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 105 000 people of more than 140 nationalities work at Novartis around the world. Find out more at www.novartis.com.
Novartis is on Twitter. Sign up to follow @Novartis at http://twitter.com/novartis
For Novartis multimedia content, please visit www.novartis.com/news/media-library
For questions about the site or required registration, please contact [email protected]
Contact Persons
Christine Fajardo
Corporate Affairs Head
Maribella Grace Sonsona
Communications Manager